CoChat

Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer

Open access
Liu, Xinlin, Deng, Junwen, Yuan, Yang, Chen, Wujun, Sun, Wenshe, Wang, Yanhong, Huang, Haiming, Liang, Bing, Ming, Tao, Wen, Jialian, Huang, Binghuan, Xing, Dongming · 2022 · Pharmacology & Therapeutics
Cited by 124

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Trop2 is a transmembrane glycoprotein and calcium signal transducer with limited expression in normal human tissues. It is consistently overexpressed in a variety of malignant tumors and participates in several oncogenic signaling pathways that lead to tumor development, invasion, and metastasis. As a result, Trop2 has become an attractive therapeutic target in cancer treatment. The anti-Trop2 antibody-drug conjugate (Trodelvy™, sacituzumab govitecan) has been approved to treat metastatic triple-negative breast cancer. However, it is still unclear whether the success observed in Trop2-positive breast cancer could be replicated in other tumor types, owing to the differences in the expression levels and functions of Trop2 across cancer types. In this review, we summarize the recent progress on the structures and functions of Trop2 and highlight the potential diagnostic and therapeutic value of Trop2 beyond breast cancer. In addition, the promising novel Trop2-targeted agents in the clinic were discussed, which will likely alter the therapeutic landscape of Trop2-positive tumors in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2022.108296

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 124

Metadata

Authors
Liu, X., Deng, J., Yuan, Y., Chen, W., Sun, W., Wang, Y., Huang, H., Liang, B., Ming, T., Wen, J., Huang, B., & Xing, D.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2022-11
Volume
239
Pages
108296
ISSN
0163-7258 (ISSN-L)
OpenAlex
W4302009910
Cited by
124
References
7
FWCI
6.35
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer. https://app.cochat.ai/papers/10.1016/j.pharmthera.2022.108296
The paper
Liu, X., Deng, J., Yuan, Y., Chen, W., Sun, W., Wang, Y., Huang, H., Liang, B., Ming, T., Wen, J., Huang, B., & Xing, D. (2022). Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2022.108296

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.